Neuro-Oncology Reviews

Volume 27 Number 7
10 March 2025

Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 7, 10 March

Gajjar A, Mahajan A, Bale T, Bowers DC, Canan L, Chi S, Cluster A, Cohen K, Cole B, Coven S, Darlington W, Dorris K, Elster J, Ermoian R, Franson A, George E, Helgager J, Landi D, Lin C, Metrock L, Nanda R, Palmer J, Partap S, Plant A, Pruthi S, Reynolds R, Stearns D, Storm P, Wang A, Wang LD, Whipple N, Zaky W, McMillian N, Ramakrishnan S.
Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
J Natl Compr Canc Netw. 2025 Mar;23(3):113-130. doi: 10.6004/jnccn.2025.0012. PMID: 40073837. Guidelines. ˍ

Kondziolka D.
Change in How We See Things: The Meningioma Story.
Neurosurgery. 2025 Mar 1;96(3):479-480. doi: 10.1227/neu.0000000000003326. PMID: 39950815. Perspective˰ ˍ

Zhan Y, Hao Y, Wang X, Guo D.
Advances of artificial intelligence in clinical application and scientific research of neuro-oncology: Current knowledge and future perspectives.
Crit Rev Oncol Hematol. 2025 Mar 1;209:104682. doi: 10.1016/j.critrevonc.2025.104682. PMID: 40032186. Review. ˍ

Rana M, Liou KC, Thakur A, Nepali K, Liou JP.
Advancing Glioblastoma Therapy: Learning From the Past and Innovations for the Future.
Cancer Lett. 2025 Mar 2:217601. doi: 10.1016/j.canlet.2025.217601. PMID: 40037502. Review˰ ˍ

Drexler R, Lim M, Hervey-Jumper SL.
Molecular-based decision-making in glioblastoma surgery: when to aim for supramaximal resection.
Neuro Oncol. 2025 Mar 3:noaf062. doi: 10.1093/neuonc/noaf062. PMID: 40037513. Review˰ ˍ

Garcia-Armengol R, Menéndez-Girón SA, Hostalot C, Pérez-Balaguero AC, Dominguez CJ, Rodriguez-Hernandez A.
Global trends in neurosurgical research: Insights from the top 100 most-cited articles.
Neurocirugia (Astur : Engl Ed). 2025 Mar 3:500656. doi: 10.1016/j.neucie.2025.500656. PMID: 40043800. Bibliometric analysis˰ ˍ

Poorva P, Mast J, Cao B, Shah MV, Pollok KE, Shen J.
Killing the Killers: Natural Killer Cell Therapy Targeting Glioma Stem Cells in High-Grade Glioma.
Mol Ther. 2025 Mar 3:S1525-0016(25)00168-6. doi: 10.1016/j.ymthe.2025.02.043. PMID: 40040281. Review. ˍ

Falcão L, Cerqueira GA, Gonçalves JPF, de Andrade JFT, de Azevedo Figueiredo Trocoli CP, Medrado-Nunes GS, Santos VEC, Pustilnik HN, Fontes JHM, Dos Passos GS.
Influence of supratotal resection on overall survival and progression of tumor in gliomas grade 2 and 3: a systematic review and meta-analysis.
Neurosurg Rev. 2025 Mar 4;48(1):281. doi: 10.1007/s10143-025-03428-x. PMID: 40032671. Review; Meta-analysis˰ ˍ

Kampers LFC, Metselaar DS, Vinci M, Scirocchi F, Veldhuijzen van Zanten S, Eyrich M, Biassoni V, Hulleman E, Karremann M, Stücker W, Van Gool SW.
The Complexity of Malignant Glioma Treatment.
Cancers (Basel). 2025 Mar 4;17(5):879. doi: 10.3390/cancers17050879. PMID: 40075726. Review. ˍ

Tariq R, Hussain N, Bajwa MH, Aziz HF, Shamim MS, Enam SA.
Multicentric low-grade glioma: A systematic review of a rare neuro-oncological disease.
Clin Neurol Neurosurg. 2025 Mar 4;251:108821. doi: 10.1016/j.clineuro.2025.108821. PMID: 40068356. Review˰ ˍ

Inggas MAM, Patel U, Wijaya JH, Otinashvili N, Menon VR, Iyer AK, Turjman T, Dadwal S, Gadaevi M, Ismayilova A, Gaddam SJ, Arya P, Upadhyay N, Kataria S.
The role of temozolomide as adjuvant therapy in glioblastoma management: a systematic review and meta-analysis.
BMC Cancer. 2025 Mar 5;25(1):399. doi: 10.1186/s12885-025-13757-1. PMID: 40045273. Review; Meta-analysis. ˍ

Rizwan A, Sridharan B, Park JH, Kim D, Vial JC, Kyhm K, Lim HG.
Nanophotonic-enhanced photoacoustic imaging for brain tumor detection.
J Nanobiotechnology. 2025 Mar 5;23(1):170. doi: 10.1186/s12951-025-03204-5. PMID: 40045308. Review. ˍ

Zhang J, Yan X, Gao X, Hu J, Zhao H, Yang C, Xu L, Niu Y, Geng M, Wang N, Hu S.
Three Decades of Photodynamic Therapy for Glioblastoma: A Comprehensive Scientometric Analysis.
Photodiagnosis Photodyn Ther. 2025 Mar 5:104533. doi: 10.1016/j.pdpdt.2025.104533. PMID: 40054646. Bibliometric analysis. ˍ

Begley SL, O'Rourke DM, Binder ZA.
CAR T Cell Therapy for Glioblastoma: A Review of the First Decade of Clinical Trials.
Mol Ther. 2025 Mar 7:S1525-0016(25)00178-9. doi: 10.1016/j.ymthe.2025.03.004. PMID: 40057825. Review. ˍ

Zhang A, Fan L, Liu Q, Zuo X, Zhu J.
Immunological Effects of Proton Radiotherapy: New Opportunities and Challenges in Cancer Therapy.
Cancer Innov. 2025 Mar 7;4(2):e70003. doi: 10.1002/cai2.70003. PMID: 40061827. Review. ˍ

Faryabi A, Salari MA, Dalvand A, Akbarniakhaky H, Mohammadi G, Aazami H, Razi F, Dehghanbanadaki H.
Mapping the landscape of vitamin D in cancer studies: a systematic global investigation.
J Diabetes Metab Disord. 2025 Mar 10;24(1):78. doi: 10.1007/s40200-025-01594-9. PMID: 40078705. Review˰ ˍ

Patel KK, Tariveranmoshabad M, Kadu S, Shobaki N, June C.
From concept to cure: The evolution of CAR-T cell therapy.
Mol Ther. 2025 Mar 10:S1525-0016(25)00179-0. doi: 10.1016/j.ymthe.2025.03.005. PMID: 40070120. Review˰ ˍ

Singh G, Rohit, Kumar P, Aran KR.
Targeting EGFR and PI3K/mTOR pathways in glioblastoma: innovative therapeutic approaches.
Med Oncol. 2025 Mar 10;42(4):97. doi: 10.1007/s12032-025-02652-1. PMID: 40064710. Review˰ ˍ